KEGG   DRUG: Nerelimomab
Entry
D05146                      Drug                                   
Name
Nerelimomab (USAN/INN)
Class
Anti-inflammatory
 DG01985  Disease modifying anti-rheumatic drug (DMARD)
  DG01936  TNF inhibitor
Efficacy
Immunosuppressant, TNF inhibitor
  Type
Monoclonal antibody
Target
TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]
  Pathway
hsa04010  MAPK signaling pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04210  Apoptosis
hsa04350  TGF-beta signaling pathway
Interaction
Brite
Drug groups [BR:br08330]
 Anti-inflammatory
  DG01985  Disease modifying anti-rheumatic drug (DMARD)
   DG01936  TNF inhibitor
    D05146  Nerelimomab
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   Tumor necrosis factors
    TNF (TNFA, TNFSF2)
     D05146  Nerelimomab (USAN/INN)
Other DBs
CAS: 162774-06-3
PubChem: 47206870
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system